Blogs

I’m a project manager in the Innovation Agency Patient Safety and Care Improvement Team, working specifically on medicines safety and optimisation programmes, and I’d like to let you know about a national improvement programme that will make a real difference to patients. 

Users of health and care services may assume that system-wide collaboration already exists – that local authority, social and domiciliary care providers, primary care networks, NHS organisations and trusts, and other critical stakeholder collaboratives are connected and communicating regularly – but this is not consistently true.

When the National Institute for Health and Care Excellence (NICE) approved the use of Inclisiran last autumn, it represented a new opportunity to make a real difference to those patients at high risk of having a heart attack or stroke.

The most deadly mental health condition is one which mainly affects young adults – and has a mortality rate of up to 20 per cent for those who are not treated.

Finding the space to breathe:tools to support innovation in asthma diagnosis and management

For the last nine months I have been on a journey to help care homes improve the way they handle medicines, which is an important part of keeping residents safe.

When I heard about this project it was an ideal opportunity for me both personally and professionally.  I’ve spent 18 years working as a nurse in acute hospital settings and making a difference to patients is why I went into nursing.  I think there are few opportunities more rewarding than improving the way in which we can look after children and young people.

After dragging on for years Brexit finally happened and, having worked on European-funded activities since the beginning of the 1990s, I have to confess I’d hoped it would never happen.

A woman lost her son after he was restrained in a seclusion room in a London hospital. She told her story at an event I attended recently and it underlined the importance of the work I am now undertaking.